课题基金 / 基金详情

The causes of MHC-I-opathies in cellular stress

The causes of MHC-I-opathies in cellular stress
细胞应激中 MHC-I 疾病的原因
批准号:
460154834
负责人:
Professor Dr. Sebastian Springer
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Professor Dr. Sebastian Springer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Major histocompatibility complex (MHC) class I molecules (termed human leukocyte antigen (HLA I in human) are essential for mounting a cytotoxic adaptive response to intracellular pathogens and tumors. The specificity of the adoptive response relies on the accurate and efficient presentation of peptide fragments from non-self (e.g., viral or neoplastic) proteins by one of each six potentially dif-ferent HLA I molecules from two equidominantly expressed alleles of HLA-A, HLA-B and HLA-C loci in each individual. Discrimination of self from non-self is safeguarded by the elimination of auto-reactive T cells. Nevertheless, a group of autoreactive diseases (e.g. ankylosing spondylitis and oth-er spondyloarthropathies, Behçet’s disease, psoriasis, birdshot chorioretinopathy) display a strong genetic link to individual HLA I alleles. Accumulation of vast genetic data over the last four decades has recently lead to classification of those autoreactive diseases as MHC-I-opathies. Interestingly, in diseased individuals, disease-related CD8+ T cell responses to specific peptide-HLA I complexes have not been detected. This suggests that there are additional immune mechanisms (e.g innate response from NK cells directed towards HLA-I; cellular stress), independent of the presented peptides. Our previous work on numerous HLA I molecules supports the idea that certain HLA I allo-types can be biochemically unstable, and that low protein stability can result in intracellular accumu-lation of misfolded HLA I proteins. In such cases, antigen presentation by HLA I is diminished at the cell surface, and accumulated HLA I can stimulate cellular stress pathways such as unfolded protein response (UPR). In this work, we will determine the stability of each individual HLA I protein associated with MHC-I-opathies, assess their link to cellular stress, and define common structural features among them. Finally, according to our expertise, we will perform screens with small molecules to improve their stability and prevent pathological phenotypes in cellular models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small molecules to manipulate peptide binding to MHC class I molecules, an optimized method for the generation of MHC tetramers by peptide exchange
  • 批准号:
    310813447
  • 项目类别:
    Research Grants (Transfer Project)
  • 资助金额:
    $0.0万
  • 财政年份:
    2016
  • 负责人:
    Professor Dr. Sebastian Springer
  • 依托单位:
Molecular cell biology of MHC class I retention by the gp40 protein of the murine cytomegalovirus
  • 批准号:
    287481932
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2015
  • 负责人:
    Professor Dr. Sebastian Springer
  • 依托单位:
Endocytic sorting of MHC class I molecules
  • 批准号:
    190867601
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2011
  • 负责人:
    Professor Dr. Sebastian Springer
  • 依托单位:
国内基金
海外基金
MHC-I/CD14介导CD8+T细胞免疫抑制促进去势抵抗前列腺癌免疫逃逸的研究
  • 批准号:
    2026JJ50277
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    钟上伟
  • 依托单位:
去泛素化酶USP9X调控抗原呈递分子MHC-I的机制研究
  • 批准号:
    JCZRQNB202600282
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
西黄丸通过m6A修饰介导YTHDF2/FAM13A/STUB1轴调控PCSK9-MHC-I信号逆转乳腺癌免疫逃逸的机制研究
BCAT2调控氨基酸代谢重编程抑制MHC-I类分子组蛋白乙酰化修饰协助免疫逃逸的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    蔡智勇
  • 依托单位: